The calculation of the Glucose Management Indicator (GMI) is influenced by the Continuous Glucose Monitoring system and patient race.
To determine whether the glucose management indicator (GMI), an estimate of hemoglobin A1c (HbA1c) derived from continuous glucose monitoring (CGM) mean glycemia, differs by CGM system and patient race. 103 patients with prediabetes or stable diabetes and a minimum of 10 days of CGM data collected with the FreeStyle Libre CGM system immediately prior to measurement of HbA1c were included in this clinic-based observational study that used data from electronic health records in an academic endocrinology clinic. HbA1c and Libre CGM measured mean glucose were plotted to derive a race-agnostic and race-specific regression equations to calculate a Libre-specific GMI (GMILi). The mean GMI derived from the published formula (GMIP) was compared with GMILi. Mean ± SD age of patients was 61.9 ± 13.3 years; 50% were of non-white race and 77% had type 2 diabetes; mean HbA1c was 62 mmol/mol (7.8%). The mean (range) number of days with available CGM data was 26 (10-90). The mean ± SD GMILi was higher than the GMIP in the entire cohort (7.9 ± 1.0% vs. 7.5 ± 1.0% respectively; p=0.01) and among Asian patients (7.9 ± 0.9% vs 7.2 ±1.0% respectively; p=0.03). In a cohort with prediabetes or stable diabetes, the regression equation to calculate GMI varied by CGM system and patient race. The development of device- and race-specific regression equations for GMI may be warranted.